Three-dimensional liver models: state of the art and their application for hepatotoxicity evaluation

References

• Aasen T, Raya A, Barrero MJ, Garreta E, Consiglio A, Gonzalez F, Vassena R, Bilić J, Pekarik V, Tiscornia G, et al. 2008. Efficient and rapid generation of induced pluripotent stem cells from human keratinocytes. Nat Biotechnol. 26(11):1276–1284.
   PubMed Web of Science ®Google Scholar
• Aden DP, Fogel A, Plotkin S, Damjanov I, Knowles BB. 1979. Controlled synthesis of HBsAg in a differentiated human liver carcinoma-derived cell line. Nature. 282(5739):615–616.
   PubMed Web of Science ®Google Scholar
• Andreas P, Paul W, Jasper D. 2010. Phospholipidosis in healthy subjects participating in clinical studies: ultrastructural findings in white blood cells. Exp Toxicol Pathol. 62:567–571.
   PubMedGoogle Scholar
• Audrey B, Céline P, Delilah H, Tracey H, Bruno H, Philippe B, Catherine S, M I, Lysiane R. 2018. 3D-spheroid primary human hepatocytes in mono- and co-culture with non-parenchymal cells. Tissue Eng Part C-Me. 24:534–545.
   Web of Science ®Google Scholar
• Aurich I, Mueller LP, Aurich H, Luetzkendorf J, Tisljar K, Dollinger MM, Schormann W, Walldorf J, Hengstler JG, Fleig WE, et al. 2007. Functional integration of hepatocytes derived from human mesenchymal stem cells into mouse livers. Gut. 56(3):405–415.
   PubMed Web of Science ®Google Scholar
• Bachour AP, Sharanek A, Burban A, Li R, Guevel RL, Abdel RZ, Stieger B, Guguen GC, Guillouzo A. 2015. Comparative localization and functional activity of the main hepatobiliary transporters in HepaRG cells and primary human hepatocytes. Toxicol Sci. 145(1):157–168.
   PubMed Web of Science ®Google Scholar
• Banas A, Teratani T, Yamamoto Y, Tokuhara M, Takeshita F, Quinn G, Okochi H, Ochiya T. 2007. Adipose tissue-derived mesenchymal stem cells as a source of human hepatocytes. Hepatology. 46(1):219–228.
   PubMed Web of Science ®Google Scholar
• Bartneck M, Warzecha KT, Tacke F. 2014. Therapeutic targeting of liver inflammation and fibrosis by nanomedicine. Hepatobiliary Surg Nutr. 3(6):364–376.
   PubMedGoogle Scholar
• Basu A, Dydowiczová A, Čtveráčková L, Jaša L, Trosko JE, Bláha L, Babica P. 2018. Assessment of hepatotoxic potential of cyanobacterial toxins using 3D in vitro model of adult human liver stem cells. Environ Sci Technol. 52(17):10078–10088.
   PubMed Web of Science ®Google Scholar
• Bell CC, Dankers ACA, Lauschke VM, Sison-Young R, Jenkins R, Rowe C, Goldring CE, Park K, Regan SL, Walker T, et al. 2018. Comparison of hepatic 2D sandwich cultures and 3D spheroids for long-term toxicity applications: A multi-center study. Toxicol Sci. 162(2):655–666.
   PubMed Web of Science ®Google Scholar
• Bell CC, Hendriks DFG, Moro SML, Ellis E, Walsh J, Renblom A, Fredriksson Puigvert L, Dankers ACA, Jacobs F, Snoeys J, et al. 2016. Characterization of primary human hepatocyte spheroids as a model system for drug-induced liver injury, liver function and disease. Sci Rep. 6(1):25187.
   PubMed Web of Science ®Google Scholar
• Bhatia SN, Ingber DE. 2014. Microfluidic organs-on-chips. Nat Biotechnol. 32(8):760–772.
   PubMed Web of Science ®Google Scholar
• Bleijs M, Wetering M, Clevers H, Drost J. 2019. Xenograft and organoid model systems in cancer research. Embo J. 38(15):e101654.
   PubMed Web of Science ®Google Scholar
• Bogaards JJ, Bertrand M, Jackson P, Oudshoorn MJ, Weaver RJ, Van Bladeren PJ, Walther B. 2000. Determining the best animal model for human cytochrome P450 activities: a comparison of mouse, rat, rabbit, dog, micropig, monkey and man. Xenobiotica. 30(12):1131–1152.
   PubMed Web of Science ®Google Scholar
• Boos JA, Misun PM, Michlmayr A, Hierlemann A, Frey O. 2019. Microfluidic multitissue platform for advanced embryotoxicity testing in vitro. Adv Sci. 6:1900294.
   Web of Science ®Google Scholar
• Broeders JJW, Parmentier C, Truisi GL, Jossé R, Alexandre E, Savary CC, Hewitt PG, Mueller SO, Guillouzo A, Richert L, et al. 2015. Biokinetics of chlorpromazine in primary rat and human hepatocytes and human HepaRG cells after repeated exposure. Toxicol in Vitro. 30(1):52–61.
   PubMed Web of Science ®Google Scholar
• Burkina V, Zlabek V, Halsne R, Ropstad E, Zamaratskaia G. 2016. In vitro effects of the citrus flavonoids diosmin, naringenin and naringin on the hepatic drug-metabolizing CYP3A enzyme in human, pig, mouse and fish. Biochem Pharmacol. 110-111:109–116.
   PubMed Web of Science ®Google Scholar
• Calitz C, Hamman J, Fey S, Viljoen A, Gouws C, Wrzesinski K. 2019. A sub-chronic Xysmalobium undulatum hepatotoxicity investigation in HepG2/C3A spheroid cultures compared to an in vivo model. J Ethnopharmacol. 239:111897.
   PubMed Web of Science ®Google Scholar
• Canaple L, Nurdin N, Angelova N, Saugy D, Hunkeler D, Desvergne B. 2001. Maintenance of primary murine hepatocyte functions in multicomponent polymer capsules-in vitro cryopreservation studies. J Hepatol. 34(1):11–18.
   PubMed Web of Science ®Google Scholar
• Chao P, Maguire T, Novik E, Cheng KC, Yarmush M. 2009. Evaluation of a microfluidic based cell culture platform with primary human hepatocytes for the prediction of hepatic clearance in human. Biochem Pharmacol. 78(6):625–632.
   PubMed Web of Science ®Google Scholar
• Chen JP, Yu SC, Hsu BRS, Fu SH, Liu HS. 2003. Loofa sponge as a scaffold for the culture of human hepatocyte cell line. Biotechnol Prog. 19(2):522–527.
   PubMed Web of Science ®Google Scholar
• Chen M, Suzuki A, Thakkar S, Yu K, Hu C, Tong W. 2016. DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans. Drug Discov Today. 21(4):648–653.
   PubMed Web of Science ®Google Scholar
• Cheng Y, Woolf TF, Gan J, He K. 2016. In vitro model systems to investigate bile salt export pump (BSEP) activity and drug interactions: a review. Chem-Biol Interact. 255:23–30.
   PubMed Web of Science ®Google Scholar
• China FDA guidance including drug-drug interactions n.d. http://samr.cfda.gov.cn/WS01/CL0844/72990.html.
   Google Scholar
• Chong TW, Smith RL, Hughes MG, Camden J, Rudy CK, Evans HL, Sawyer RG, Pruett TL. 2006. Primary human hepatocytes in spheroid formation to study Hepatitis C infection1. J Surg Res. 130(1):52–57.
   PubMed Web of Science ®Google Scholar
• Christoffersson J. 2019. Organs-on-chips for the pharmaceutical development process: design perspectives and implementations. Vol. 1907. Sweden: Linköping University Electronic Press.
   Google Scholar
• Chun MH. 1997. Plasmin induces the formation of multicellular spheroids of breast cancer cells. Cancer Lett. 117(1):51–56.
   PubMed Web of Science ®Google Scholar
• Cui J, Wang H, Shi Q, Sun T, Huang Q, Fukuda T. 2019. Multicellular co-culture in three-dimensional gelatin methacryloyl hydrogels for liver tissue engineering. Molecules. 24(9):e1762.
   PubMed Web of Science ®Google Scholar
• Dash A, Figler RA, Sanyal AJ, Wamhoff BR. 2017. Drug-induced steatohepatitis. Expert Opin Drug Metab Toxicol. 13(2):193–204.
   PubMed Web of Science ®Google Scholar
• Deharde D, Schneider C, Hiller T, Fischer N, Kegel V, Lübberstedt M, Freyer N, Hengstler JG, Andersson TB, Seehofer D, et al. 2016. Bile canaliculi formation and biliary transport in 3D sandwich-cultured hepatocytes in dependence of the extracellular matrix composition. Arch Toxicol. 90(10):2497–2511.
   PubMed Web of Science ®Google Scholar
• DelRaso N. 1993. In vitro methodologies for enhanced toxicity testing. Toxicol Lett. 68(1-2):91–99.
   PubMed Web of Science ®Google Scholar
• Depreter M, Walker T, Smet KD, Beken S, Kerckaert I, Rogiers V, Roels F. 2002. Hepatocyte polarity and the peroxisomal compartment: a comparative study. Histochem J. 34(3/4):139–151.
   PubMedGoogle Scholar
• Desai PK, Tseng H, Souza GR. 2017. Assembly of hepatocyte spheroids using magnetic 3D cell culture for CYP450 inhibition/induction. IJMS. 18(5):1085–1097.
   Google Scholar
• Dilworth C, Hamilton GA, George E, Timbrell JA. 2000. The use of liver spheroids as an in vitro model for studying induction of the stress response as a marker of chemical toxicity. Toxicol in Vitro. 14(2):169–176.
   PubMed Web of Science ®Google Scholar
• Drewitz M, Helbling M, Fried N, Bieri M, Moritz W, Lichtenberg J, Kelm JM. 2011. Towards automated production and drug sensitivity testing using scaffold-free spherical tumor microtissues. Biotechnol J. 6(12):1488–1496.
   PubMed Web of Science ®Google Scholar
• Drost J, Clevers H. 2018. Organoids in cancer research. Nat Rev Cancer. 18(7):407–418.
   PubMed Web of Science ®Google Scholar
• Dubiak-Szepietowska M, Karczmarczyk A, Jonsson-Niedziołka M, Winckler T, Feller KH. 2016. Development of complex-shaped liver multicellular spheroids as a human-based model for nanoparticle toxicity assessment in vitro. Toxicol Appl Pharmacol. 294:78–85.
   PubMed Web of Science ®Google Scholar
• Dunn JC, Yarmush ML, Koebe HG, Tompkins RG. 1989. Hepatocyte function and extracellular matrix geometry: long-term culture in a sandwich configuration. FASEB J. 3(2):174–177.
   PubMed Web of Science ®Google Scholar
• EMA Guideline on Drug Interaction. 2012. Guideline on the investigation of drug interactions. Committee for Human Medicinal Products.
   Google Scholar
• FDA guidance on drug-drug interaction n.d. Drug interaction studies-study design, data analysis, implications for dosing and labeling recommendations. http://www.fda.gov/downloads/Drugs/Guidance-ComplianceRegulatoryInformation/Guidances/UCM072101.pdf.
   Google Scholar
• FDA guidance on drug-induced liver injury. 2009. Drug-induced liver injury: premarketing clinical evaluation.
   Google Scholar
• Fey SJ, Wrzesinski K. 2012. Determination of drug toxicity using 3D spheroids constructed from an immortal human hepatocyte cell line. Toxicol Sci. 127(2):403–411.
   PubMed Web of Science ®Google Scholar
• Fleddermann J, Susewind J, Peuschel H, Koch M, Tavernaro I, Kraegeloh A. 2019. Distribution of SiO2 nanoparticles in 3D liver microtissues. IJN. 14:1411–1431.
   Google Scholar
• Foster AJ, Chouhan B, Regan SL, Rollison H, Amberntsson S, Andersson LC, Srivastava A, Darnell M, Cairns J, Lazic SE, et al. 2019. Integrated in vitro models for hepatic safety and metabolism: evaluation of a human Liver-Chip and liver spheroid. Arch Toxicol. 93(4):1021–1037.
   PubMed Web of Science ®Google Scholar
• Foty R. 2011. A simple hanging drop cell culture protocol for generation of 3D spheroids. JoVE. 51:e2720–e2720.
   Google Scholar
• Gao Y, Jiang HC, Xu J, Pan SH, Li YD. 2005. Microencapsulating hepatocytes. Transplant Proc. 37(10):4589–4593.
   PubMed Web of Science ®Google Scholar
• Garcia JC, Peris MD, Alcoriza MI, Cerdan M, Donato MT, Lahoz A. 2017. A lipidomic cell-based assay for studying drug-induced phospholipidosis and steatosis. Electrophoresis. 38(18):2331–2340.
   PubMed Web of Science ®Google Scholar
• Gaskell H, Sharma P, Colley HE, Murdoch C, Williams DP, Webb SD. 2016. Characterization of a functional C3A liver spheroid model. Toxicol Res. 5(4):1053–1065.
   PubMed Web of Science ®Google Scholar
• Gerets H, Tilmant K, Gerin B, Chanteux H, Depelchin B, Dhalluin S, Atienzar F. 2012. Characterization of primary human hepatocytes, HepG2 cells, and HepaRG cells at the mRNA level and CYP activity in response to inducers and their predictivity for the detection of human hepatotoxins. Cell Biol Toxicol. 28(2):69–87.
   PubMed Web of Science ®Google Scholar
• Gevaert E, Dollé L, Billiet T, Dubruel P, Van GL, Van AA, Cornelissen R. 2014. High throughput micro-well generation of hepatocyte micro-aggregates for tissue engineering. PLoS One. 9(8):e105171.
   PubMed Web of Science ®Google Scholar
• Gomez MJ, Tolosa L. 2016. Human hepatocytes derived from pluripotent stem cells: a promising cell model for drug hepatotoxicity screening. Arch Toxicol. 90(9):2049–2061.
   PubMed Web of Science ®Google Scholar
• Gong X, Lin C, Cheng J, Su J, Zhao H, Liu T, Wen X, Zhao P. 2015. Generation of Multicellular Tumor Spheroids with Microwell-Based Agarose Scaffolds for Drug Testing. PLoS One. 10(6):e0130348.
   PubMed Web of Science ®Google Scholar
• Gonzalez FJ, Bonzo JA, Ferry CH, Matsubara T, Kim JH. 2012. Suppression of hepatocyte proliferation by hepatocyte nuclear factor 4α in adult mice. J Biol Chem. 287(10):7345–7356.
   PubMed Web of Science ®Google Scholar
• Gripon P, Rumin S, Urban S, Le Seyec J, Glaise D, Cannie I, Guyomard C, Lucas J, Trepo C, Guguen-Guillouzo C. 2002. Infection of a human hepatoma cell line by hepatitis B virus. P Natl Ac Ad Sci USA. 99(24):15655–15660.
   PubMed Web of Science ®Google Scholar
• Guguen GC, Corlu A, Guillouzo A. 2010. Stem cell-derived hepatocytes and their use in toxicology. Toxicology. 270(1):3–9.
   PubMed Web of Science ®Google Scholar
• Guguen GC, Guillouzo A. 2019. Setup and use of hepaRG cells in cholestasis research. Experimental Cholestasis Research. New York, NY: Humana Press, p. 291–312.
   Google Scholar
• Gunness P, Mueller D, Shevchenko V, Heinzle E, Ingelman SM, Noor F. 2013. 3D organotypic cultures of human HepaRG cells: a tool for in vitro toxicity studies. Toxicol Sci. 133(1):67–78.
   PubMed Web of Science ®Google Scholar
• Gunther C, Brevini T, Sampaziotis F, Neurath MF. 2019. What gastroenterologists and hepatologists should know about organoids in 2019. Dig Liver Dis. 51(6):753–760.
   PubMedGoogle Scholar
• Guo L, Dial S, Shi L, Branham W, Liu J, Fang JL, Green B, Deng H, Kaput J, Ning B. 2011. Similarities and differences in the expression of drug-metabolizing enzymes between human hepatic cell lines and primary human hepatocytes. Drug Metab Dispos. 39(3):528–538.
   PubMed Web of Science ®Google Scholar
• Hamazaki K, Doi Y, Koide N. 2002. Microencapsulated multicellular spheroid of rat hepatocytes transplanted intraperitoneally after 90% hepatectomy. Hepatogastroenterology. 49(48):1514–1516.
   PubMedGoogle Scholar
• Hanumegowda UM, Wenke G, Regueiro RA, Yordanova R, Corradi JP, Adams SP. 2010. Phospholipidosis as a function of basicity, lipophilicity, and volume of distribution of compounds. Chem Res Toxicol. 23(4):749–755.
   PubMed Web of Science ®Google Scholar
• Hartley BJ, Brennand KJ. 2017. Neural organoids for disease phenotyping, drug screening and developmental biology studies. Neurochem Int. 106:85–93.
   PubMed Web of Science ®Google Scholar
• Hasebe Y, Okumura N, Koh T, Kazama H, Watanabe G, Seki T, Ariga T. 2005. Formation of rat hepatocyte spheroids on agarose. Hepatol Res. 32(2):89–95.
   PubMed Web of Science ®Google Scholar
• Hendriks DF, Fredriksson Puigvert L, Messner S, Moritz W, Ingelman Sundberg M. 2016. Hepatic 3D spheroid models for the detection and study of compounds with cholestatic liability. Toxicol Lett. 258:S134–S135.
   PubMed Web of Science ®Google Scholar
• Hengstler JG, Utesch D, Steinberg P, Platt KL, Diener B, Ringel M, Swales N, Fischer T, Biefang K, Gerl M, et al. 2000. Cryopreserved primary hepatocytes as a constantly available in vitro model for the evaluation of human and animal drug metabolism and enzyme induction. Drug Metab Rev. 32(1):81–118.
   PubMed Web of Science ®Google Scholar
• Hori T, Kurosawa O. 2018. A three-dimensional cell culture method with a micromesh sheet and its application to hepatic cells. Tissue Eng Part C Methods. 24(12):730–739.
   Web of Science ®Google Scholar
• Hou D, Arimura M, Fukuda M, Oka T, Fujii M. 2001. Expression of cell adhesion molecule and albumin genes in primary culture of rat hepatocytes. Cell Biol Int. 25(3):239–244.
   PubMed Web of Science ®Google Scholar
• Hurrell T, Lilley KS, Cromarty AD. 2019. Proteomic responses of HepG2 cell monolayers and 3D spheroids to selected hepatotoxins. Toxicol Lett. 300:40–50.
   PubMed Web of Science ®Google Scholar
• Iansante V, Chandrashekran A, Dhawan A. 2018. Cell-based liver therapies: past, present and future. Phil Trans R Soc B. 373(1750):20170229.
   PubMed Web of Science ®Google Scholar
• ICH guideline genotoxicity. 2011. Guideline on genotoxicity testing and data interpretation for pharmaceuticals intended for human use S2(R1).
   Google Scholar
• ICH M3. 2010. M3(R2) Nonclinical safety studies for the conduct of human clinical trials and marketing authorization for pharmaceuticals.
   Google Scholar
• Ifkovits JL, Burdick JA. 2007. Review: photopolymerizable and degradable biomaterials for tissue engineering applications. Tissue Eng. 13(10):2369–2385.
   PubMedGoogle Scholar
• Introduction from Cyprio Website n.d. Introduction from cyprio website for hepatocyte products. https://www.cyprio.fr/product/.
   Google Scholar
• Jang KJ, Otieno MA, Ronxhi J, Lim HK, Ewart L, Kodella K, Petropolis D, Kulkarni G, Rubins JE, Conegliano D. 2019. Liver-chip: reproducing human and cross-species toxicities. bioRxiv. 11(517):631002.
   Google Scholar
• Juergen F, Claudia S, Reinhard E, Kunz LA. 2009. Spheroid-based drug screen: considerations and practical approach. Nat Protoc. 4:309–324.
   PubMed Web of Science ®Google Scholar
• Jungwoo L, Daniel L, Christopher D, Paul P, Kotov NA. 2009. In vitro toxicity testing of nanoparticles in 3D cell culture. Small. 5:NA–1221.
   Web of Science ®Google Scholar
• Kajsa PK. 2008. Evaluation of HepaRG cells as an in vitro model for human drug metabolism studies. Drug Metab Dispos. 7:1444–1452.
   Google Scholar
• Kasahara T, Tomita K, Murano H, Harada T, Tsubakimoto K, Ogihara T, Ohnishi S, Kakinuma C. 2006. Establishment of an in vitro high-throughput screening assay for detecting phospholipidosis-inducing potential. Toxicol Sci. 90(1):133–141.
   PubMed Web of Science ®Google Scholar
• Kawai M, Saegusa Y, Kemmochi S, Harada T, Shimamoto K, Shibutani M, Mitsumori K. 2010. Cytokeratin 8/18 is a useful immunohistochemical marker for hepatocellular proliferative lesions in mice. J Vet Med Sci. 72(3):263–269.
   PubMed Web of Science ®Google Scholar
• Keller GM. 1995. In vitro differentiation of embryonic stem cells. Curr Opin Cell Biol. 7(6):862–869.
   PubMed Web of Science ®Google Scholar
• Kelly JH, Darlington GJ. 1989. Modulation of the liver specific phenotype in the human hepatoblastoma line Hep G2. In Vitro Cell Dev Biol. 25(2):217–222.
   PubMed Web of Science ®Google Scholar
• Kelm JM, Timmins NE, Brown CJ, Martin F, Nielsen LK. 2003. Method for generation of homogeneous multicellular tumor spheroids applicable to a wide variety of cell types. Biotechnol Bioeng. 83(2):173–180.
   PubMed Web of Science ®Google Scholar
• Kermanizadeh A, L Hr M, Roursgaard M, Messner S, Gunness P, Kelm JM, Møller P, Stone V, Loft S. 2014. Hepatic toxicology following single and multiple exposure of engineered nanomaterials utilising a novel primary human 3D liver microtissue model. Part Fibre Toxicol. 11(1):56–71.
   PubMed Web of Science ®Google Scholar
• Kermanizadeh A. 2019. Preparation and Utilization of a 3D human liver microtissue model for nanotoxicological assessment. Nanotoxicity. 1894:47–55.
   Google Scholar
• Kian NC, Wei SL, Pengchi Z, Hongfang L, Jie W, Seeram R, Leong KW, Hai QM. 2005. Stable immobilization of rat hepatocyte spheroids on galactosylated nanofiber scaffold. Biomaterials. 26(15):2537–2547.
   PubMed Web of Science ®Google Scholar
• Kim J, Kim Y, Choi J, Jung H, Lee K, Kang J, Park N, Rim YA, Nam Y, Ju JH. 2018. Recapitulation of methotrexate hepatotoxicity with induced pluripotent stem cell-derived hepatocytes from patients with rheumatoid arthritis. Stem Cell Res Ther. 9(1):357–372.
   PubMedGoogle Scholar
• Kim Y, Kang K, Yoon S, Kim JS, Park SA, Kim WD, Lee SB, Ryu KY, Jeong J, Choi D. 2018. Prolongation of liver-specific function for primary hepatocytes maintenance in 3D printed architectures. Organogenesis. 14(1):1–12.
   PubMed Web of Science ®Google Scholar
• Klaus J, Kanton S, Kyrousi C, Ayo-Martin AC, Di Giaimo R, Riesenberg S, O’Neill AC, Camp JG, Tocco C, Santel M, et al. 2019. Altered neuronal migratory trajectories in human cerebral organoids derived from individuals with neuronal heterotopia. Nat Med. 25(4):561–575.
   PubMed Web of Science ®Google Scholar
• Klotz BJ, Gawlitta D, Rosenberg AJ, Malda J, Melchels FP. 2016. Gelatin-methacryloyl hydrogels: towards biofabrication-based tissue repair. Trends Biotechnol. 34(5):394–407.
   PubMed Web of Science ®Google Scholar
• Koide N, Sakaguchi K, Koide Y, Asano K, Kawaguchi M, Matsushima H, Takenami T, Shinji T, Mori M, Tsuji T. 1990. Formation of multicellular spheroids composed of adult rat hepatocytes in dishes with positively charged surfaces and under other nonadherent environments. Exp Cell Res. 186(2):227–235.
   PubMed Web of Science ®Google Scholar
• Koide N, Shinji T, Tanabe T, Asano K, Kawaguchi M, Sakaguchi K, Koide Y, Mori M, Tsuji T. 1989. Continued high albumin production by multicellular spheroids of adult rat hepatocytes formed in the presence of liver-derived proteoglycans. Biochem Biophys Res Commun. 161(1):385–391.
   PubMed Web of Science ®Google Scholar
• Kozyra M, Johansson I, Nordling A, Ullah S, Lauschke VM, Ingelman SM. 2018. Human hepatic 3D spheroids as a model for steatosis and insulin resistance. Sci Rep. 8(1):14297–14309.
   PubMed Web of Science ®Google Scholar
• Lake BG, Price RJ, Giddings AM, Walters DG. 2009. In vitro assays for induction of drug metabolism. Methods Mol Biol. 481:47–58.
   PubMedGoogle Scholar
• Landry J, Bernier D, Ouellet C, Goyette R, Marceau N. 1985. Spheroidal aggregate culture of rat liver cells: histotypic reorganization, biomatrix deposition, and maintenance of functional activities. J Cell Biol. 101(3):914–923.
   PubMed Web of Science ®Google Scholar
• Lauschke VM, Vorrink SU, Moro SML, Rezayee F, Nordling Å, Hendriks DFG, Bell CC, Sison-Young R, Park BK, Goldring CE, et al. 2016. Massive rearrangements of cellular MicroRNA signatures are key drivers of hepatocyte dedifferentiation. Hepatology. 64(5):1743–1756.
   PubMed Web of Science ®Google Scholar
• LeCluyse EL, Bullock PL, Parkinson A. 1996. Strategies for restoration and maintenance of normal hepatic structure and function in long-term cultures of rat hepatocytes. Adv Drug Del Rev. 22(1-2):133–186.
   Web of Science ®Google Scholar
• Lee H-J, Son MJ, Ahn J, Oh SJ, Lee M, Kim A, Jeung Y-J, Kim H-G, Won M, Lim JH, et al. 2017. Elasticity-based development of functionally enhanced multicellular 3D liver encapsulated in hybrid hydrogel. Acta Biomater. 64:67–79.
   PubMed Web of Science ®Google Scholar
• Li J, He X, Zou Y, Chen D, Yang L, Rao J, Chen H, Chan MCW, Li L, Guo Z, et al. 2017. Mitochondria-targeted platinum (ii) complexes: dual inhibitory activities on tumor cell proliferation and migration/invasion via intracellular trafficking of β-catenin. Metallomics. 9(6):726–733.
   PubMed Web of Science ®Google Scholar
• Liu J, Li R, Xue R, Li T, Leng L, Wang Y, Wang J, Ma J, Yan J, Yan F, et al. 2018. Liver Extracellular matrices bioactivated hepatic spheroids as a model system for drug hepatotoxicity evaluations. Adv Biosys. 2(10):1800110.
   Web of Science ®Google Scholar
• Low L, Tagle D. 2017. Microphysiological systems (“organs-on-chips”) for drug efficacy and toxicity testing. Clin Trans Sci. 10(4):237–239.
   PubMed Web of Science ®Google Scholar
• Ma X, Qu X, Zhu W, Li Y-S, Yuan S, Zhang H, Liu J, Wang P, Lai CSE, Zanella F, et al. 2016. Deterministically patterned biomimetic human iPSC-derived hepatic model via rapid 3D bioprinting. Proc Natl Acad Sci Usa. 113(8):2206–2211.
   PubMed Web of Science ®Google Scholar
• March S, Ramanan V, Trehan K, Ng S, Galstian A, Gural N, Scull MA, Shlomai A, Mota MM, Fleming HE, et al. 2015. Micropatterned coculture of primary human hepatocytes and supportive cells for the study of hepatotropic pathogens. Nat Protoc. 10(12):2027–2053.
   PubMed Web of Science ®Google Scholar
• Mavri DD, Eaton S, Damelin LH, Rees M, Hodgson HJ, Selden C. 2007. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2. Int J of Biochem Cell B. 39(3):555–564.
   PubMedGoogle Scholar
• Mayati A, Moreau A, Le Vée M, Bruyère A, Jouan E, Denizot C, Parmentier Y, Fardel O. 2018. Functional polarization of human hepatoma HepaRG cells in response to forskolin. Sci Rep. 8(1):16115–16130.
   PubMedGoogle Scholar
• Messner S, Agarkova I, Moritz W, Kelm J. 2013. Multi-cell type human liver microtissues for hepatotoxicity testing. Arch Toxicol. 87(1):209–213.
   PubMed Web of Science ®Google Scholar
• Mitaka T, Sato F, Mizuguchi T, Yokono T, Mochizuki Y. 1999. Reconstruction of hepatic organoid by rat small hepatocytes and hepatic nonparenchymal cells. Hepatology. 29(1):111–125.
   PubMed Web of Science ®Google Scholar
• Monostory K, Kőhalmy K, Prough RA, Kóbori L, Vereczkey L. 2005. The effect of synthetic glucocorticoid, dexamethasone on CYP1A1 inducibility in adult rat and human hepatocytes. FEBS Lett. 579(1):229–235.
   PubMed Web of Science ®Google Scholar
• Mukherjee S, Zhelnin L, Sanfiz A, Pan J, Li Z, Yarde M, McCarty J, Jarai G. 2019. Development and validation of an in vitro 3D model of NASH with severe fibrotic phenotype. Am J Trans Res. 11:1531–1540.
   PubMed Web of Science ®Google Scholar
• Nakamura M, Shinji T, Ujike K, Hirasaki S, Koide N, Tsuji T. 2002. Cytoskeletal inhibitors, anti-adhesion molecule antibodies, and lectins inhibit hepatocyte spheroid formation. Acta Med Okayama. 56(1):43–50.
   PubMed Web of Science ®Google Scholar
• Nam YS, Yoon JJ, Lee JG, Park TG. 1999. Adhesion behaviours of hepatocytes cultured onto biodegradable polymer surface modified by alkali hydrolysis process. J Biomater Sci Polym Ed. 10(11):1145–1158.
   PubMed Web of Science ®Google Scholar
• Napolitano AP, Dean DM, Man AJ, Youssef J, Ho DN, Rago AP, Lech MP, Morgan JR. 2007. Scaffold-free three-dimensional cell culture utilizing micromolded nonadhesive hydrogels. BioTechniques. 43(4):494–500.
   PubMed Web of Science ®Google Scholar
• Natale A, Vanmol K, Arslan A, Van Vlierberghe S, Dubruel P, Van Erps J, Thienpont H, Buzgo M, Boeckmans J, De Kock J, et al. 2019. Technological advancements for the development of stem cell-based models for hepatotoxicity testing. Arch Toxicol. 93(7):1789–1717.
   PubMed Web of Science ®Google Scholar
• Nelson LJ, Morgan K, Treskes P, Samuel K, Henderson CJ, LeBled C, Homer N, Grant MH, Hayes PC, Plevris JN. 2017. Human hepatic HepaRG cells maintain an organotypic phenotype with high intrinsic CYP450 activity/metabolism and significantly outperform standard HepG2/C3A cells for pharmaceutical and therapeutic applications. Basic Clin Pharmacol Toxicol. 120(1):30–37.
   PubMed Web of Science ®Google Scholar
• News from Corning website n.d. Introducing corning Elplasia® plates. https://www.corning.com/worldwide/en/products/life-sciences/products/microplates/elplasia-plates.html.
   Google Scholar
• News from Epicos website. 2017. 3D Cell culture market key manufacturers. https://www.epicos.com/article/135879/3d-cell-culture-market-key-manufacturers-corning-3d-biotek-and-lonza-group-says-new.
   Google Scholar
• News from INDIGO website. In vitro screening for drug-induced hepatotoxicity using upcyte® Hepatocytes. https://indigobiosciences.com/in-vitro-toxicology/.
   Google Scholar
• News from Insphero website. 2015. InSphero receives EUR 750K funding from EU-ToxRisk.https://insphero.com/media-release/21-10-2015-insphero-receives-eur-750k-funding-from-eu-toxrisk-consortium.
   Google Scholar
• News from Marketsandmarkets website 2019. The report of the 3D cell culture market.https://www.marketsandmarkets.com/Market-Reports/3d-cell-culture-market-191072847.
   Google Scholar
• News from Wiki website n.d. America animal welfare act. https://en.wikipedia.org/wiki/Animal_Welfare_Act_of_1966US.code.
   Google Scholar
• Novik E, Maguire TJ, Chao P, Cheng K, Yarmush ML. 2010. A microfluidic hepatic coculture platform for cell-based drug metabolism studies. Biochem Pharmacol. 79(7):1036–1044.
   PubMed Web of Science ®Google Scholar
• Nugraha B, Buono MF, von Boehmer L, Hoerstrup SP, Emmert MY. 2019. Human cardiac organoids for disease modeling. Clin Pharmacol Ther. 105(1):79–85.
   PubMed Web of Science ®Google Scholar
• OECD guideline. OECD guidelines for the testing of chemicals, section 4 for health effects. https://www.oecd-ilibrary.org/environment/oecd-guidelines-for-the-testing-of-chemicals-section-4-health-effects_20745788.
   Google Scholar
• Olson H, Betton G, Robinson D, Thomas K, Monro A, Kolaja G, Lilly P, Sanders J, Sipes G, Bracken W, et al. 2000. Concordance of the toxicity of pharmaceuticals in humans and in animals. Regul Toxicol Pharmacol. 32(1):56–67.
   PubMed Web of Science ®Google Scholar
• Palakkan AA, Hay DC, Pr AK, Tv K, Ross JA. 2013. Liver tissue engineering and cell sources: issues and challenges. Liver Int. 33(5):666–676.
   PubMed Web of Science ®Google Scholar
• Park JK, Utsumi T, Seo YE, Deng Y, Satoh A, Saltzman WM, Iwakiri Y. 2016. Cellular distribution of injected PLGA-nanoparticles in the liver. Nanomed Nanotechnol Biol Med. 12(5):1365–1374.
   PubMed Web of Science ®Google Scholar
• Parmentier C, Hendriks DF, Heyd B, Bachellier P, Ingelman-Sundberg M, Richert L. 2018. Inter-individual differences in the susceptibility of primary human hepatocytes towards drug-induced cholestasis are compound and time dependent. Toxicol Lett. 295:187–194.
   PubMed Web of Science ®Google Scholar
• Pavlik L, Regev A, Ardayfio PA, Chalasani NP. 2019. Drug-induced steatosis and steatohepatitis: the search for novel serum biomarkers among potential biomarkers for non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Drug Saf. 42(6):701–711.
   PubMed Web of Science ®Google Scholar
• Pohl W. 1959. Substructure and function of liver cell organoids. Munch Med Wochenschr. 101(8):334–336.
   PubMedGoogle Scholar
• PR China regulation on human genetic resource. Decree of the State Council #717. Enacted by the China State Council in 2019. http://www.gov.cn/zhengce/content/2019-06/10/content_5398829.htm.
   Google Scholar
• Proctor WR, Foster AJ, Vogt J, Summers C, Middleton B, Pilling MA, Shienson D, Kijanska M, Ströbel S, Kelm JM, et al. 2017. Utility of spherical human liver microtissues for prediction of clinical drug-induced liver injury. Arch Toxicol. 91(8):2849–2863.
   PubMed Web of Science ®Google Scholar
• Qian X, Song H, Ming GL. 2019. Brain organoids: advances, applications and challenges. Development. 146(8):dev166074.
   PubMed Web of Science ®Google Scholar
• Ramaiahgari SC, Den Braver MW, Herpers B, Terpstra V, Commandeur JN, van de Water B, Price LS. 2014. A 3D in vitro model of differentiated HepG2 cell spheroids with improved liver-like properties for repeated dose high-throughput toxicity studies. Arch Toxicol. 88(5):1083–1095.
   PubMed Web of Science ®Google Scholar
• Ramaiahgari SC, Ferguson SS. 2019. Organotypic 3D HepaRG liver model for assessment of drug-induced cholestasis. Experimental Cholestasis Research. New York, NY: Humana Press, p. 313–323.
   Google Scholar
• Ramaiahgari SC, Waidyanatha S, Dixon D, Devito MJ, Paules RS, Ferguson SS. 2017. Three-dimensional (3D) HepaRG spheroid model with physiologically-relevant xenobiotic metabolism competence and hepatocyte functionality for liver toxicity screening. Toxicol Sci. 159(1):124–136.
   PubMed Web of Science ®Google Scholar
• Raska J, Ctverackova L, Dydowiczova A, Sovadinova I, Blaha L, Babica P. 2018. Tumor-promoting cyanotoxin microcystin-LR does not induce procarcinogenic events in adult human liver stem cells. Toxicol Appl Pharm. 345:103–113.
   PubMed Web of Science ®Google Scholar
• Ravenscroft Corning/Cyprotex n.d. Comparison of ultra-low attachment spheroid microplates and hanging drop for microtissue formation and high content screening. From http://www.corning.com/lifesciences.
   Google Scholar
• Raymond R, Johan K, Georgia G, Lynette B, David W, Seddik H, Brigitte BT, Amruta V, Simone M, Kaye PM. 2015. Bile canalicular dynamics in hepatocyte sandwich cultures. Arch Toxicol. 89:1861–1870.
   Google Scholar
• Rebelo SP, Costa R, Silva MM, Marcelino P, Brito C, Alves PM. 2017. Three‐dimensional co‐culture of human hepatocytes and mesenchymal stem cells: improved functionality in long‐term bioreactor cultures. J Tissue Eng Regen Med. 11(7):2034–2045.
   PubMed Web of Science ®Google Scholar
• Redegeld FAM, Moison RMW, Koster AS, Noordhoek J. 1992. Depletion of ATP but not of GSH affects viability of rat hepatocytes. Eurjpharmacol. 228(4):229–236.
   Google Scholar
• Regulation on experimental animals n.d. Enacted by the China state council in 2017. http://www.gov.cn/gongbao/content/2017/content_5219148.htm.
   Google Scholar
• Regulations on human organ transplantation. Decree of the state council #491. enacted by the China state council in 2007.
   Google Scholar
• Rivron NC, Vrij EJ, Rouwkema J, Le Gac S, van den Berg A, Truckenmuller RK, van Blitterswijk CA. 2012. Tissue deformation spatially modulates VEGF signaling and angiogenesis. Proc Natl Acad Sci USA. 109(18):6886–6891.
   PubMed Web of Science ®Google Scholar
• Rossi EA, Quintanilha LF, Nonaka CKV, Souza B. 2019. Advances in Hepatic Tissue Bioengineering with Decellularized Liver Bioscaffold. Stem Cells Int. 2019:1–13.
   Web of Science ®Google Scholar
• Sachinidis A, Albrecht W, Nell P, Cherianidou A, Hewitt NJ, Edlund K, Hengstler JG. 2019. Road map for development of stem cell-based alternative test methods. Trends Mol Med. 25(6):470–481.
   PubMed Web of Science ®Google Scholar
• Schumacher JD, Guo GL. 2015. Mechanistic review of drug-induced steatohepatitis. Toxicol Appl Pharmacol. 289(1):40–47.
   PubMed Web of Science ®Google Scholar
• Senyavina N, Gerasimenko T, Pulkova N, Maltseva D. 2016. Transport and toxicity of silver nanoparticles in HepaRG cell spheroids. Bull Exp Biol Med. 160(6):831–834.
   PubMed Web of Science ®Google Scholar
• Shah UK, Mallia DO, Singh N, Chapman KE, Doak SH, Jenkins JS. 2018. A three-dimensional in vitro HepG2 cells liver spheroid model for genotoxicity studies. Mutat Res. 825:51–58.
   PubMed Web of Science ®Google Scholar
• Shin DS, Seo H, Yang JY, Joo J, Im SH, Kim SS, Kim SK, Bae MA. 2018. Quantitative evaluation of cytochrome P450 3A4 inhibition and hepatotoxicity in HepaRG 3D spheroids. Int J Toxicol. 37(5):393–403.
   PubMed Web of Science ®Google Scholar
• Shinji T, Koide N, Tsuji T. 1988. Glycosaminoglycans partially substitute for proteoglycans in spheroid formation of adult rat hepatocytes in primary culture. Cell Struct Funct. 13(2):179–188.
   PubMed Web of Science ®Google Scholar
• Shri M, Agrawal H, Rani P, Singh D, Onteru SK. 2017. Hanging drop, a best three-dimensional (3D) culture method for primary buffalo and sheep hepatocytes. Sci Rep. 7(1):1203–1217.
   PubMedGoogle Scholar
• Sin A, Chin KC, Jamil MF, Kostov Y, Rao G, Shuler ML. 2008. The design and fabrication of three-chamber microscale cell culture analog devices with integrated dissolved oxygen sensors. Biotechnol Progress. 20(1):338–345.
   Google Scholar
• Sirenko O, Hancock MK, Hesley J, Hong D, Cohen A, Gentry J, Carlson CB, Mann DA. 2016. Phenotypic characterization of toxic compound effects on liver spheroids derived from iPSC using confocal imaging and three-dimensional image analysis. Assay Drug Dev Techn. 14(7):381–394.
   PubMed Web of Science ®Google Scholar
• Souza GR, Molina JR, Raphael RM, Ozawa MG, Stark DJ, Levin CS, Bronk LF, Ananta JS, Mandelin J, Georgescu M-M, et al. 2010. Three-dimensional tissue culture based on magnetic cell levitation. Nature Nanotech. 5(4):291–296.
   PubMed Web of Science ®Google Scholar
• Stevens JL, Baker TK. 2009. The future of drug safety testing: expanding the view and narrowing the focus. Drug Discov Today. 14(3–4):162–167.
   PubMed Web of Science ®Google Scholar
• Stieger B. 2011. The role of the sodium-taurocholate cotransporting polypeptide (NTCP) and of the bile salt export pump (BSEP) in physiology and pathophysiology of bile formation. Drug transporters. Springer; p. 205–259.
   Google Scholar
• Stoehr SA, Isom HC. 2003. Gap junction-mediated intercellular communication in a long-term primary mouse hepatocyte culture system. Hepatology. 38(5):1125–1135.
   PubMed Web of Science ®Google Scholar
• Takagi M, Sanoh S, Santoh M, Ejiri Y, Kotake Y, Ohta S. 2016. Detection of metabolic activation leading to drug-induced phospholipidosis in rat hepatocyte spheroids. J Toxicol Sci. 41(1):155–164.
   PubMed Web of Science ®Google Scholar
• Takahashi K, Yamanaka S. 2006. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 126(4):663–676.
   PubMed Web of Science ®Google Scholar
• Takayama K, Kawabata K, Nagamoto Y, Kishimoto K, Tashiro K, Sakurai F, Tachibana M, Kanda K, Hayakawa T, Furue MK, et al. 2013. 3D spheroid culture of hESC/hiPSC-derived hepatocyte-like cells for drug toxicity testing. Biomaterials. 34(7):1781–1789.
   PubMed Web of Science ®Google Scholar
• Takayama K, Mizuguchi H. 2017. Generation of human pluripotent stem cell-derived hepatocyte-like cells for drug toxicity screening. Drug Metab Pharmacokinet. 32(1):12–20.
   PubMed Web of Science ®Google Scholar
• Takayama K. 2015. Establishment of a method of hepatocyte differentiation from human pluripotent stem cells for innovative drug development. Yakugaku Zasshi. 135(10):1141–1146.
   PubMed Web of Science ®Google Scholar
• Tania M, Hsu MN, Png SN, Leo HL, Toh GW, Birgersson E. 2014. Perfusion enhanced polydimethylsiloxane based scaffold cell culturing system for multi-well drug screening platform. Biotechnol Progress. 30(2):418–428.
   PubMed Web of Science ®Google Scholar
• Teresa DM, Jose GM. 2012. Drug-induced liver steatosis and phospholipidosis: cell-based assays for early screening of drug candidates. Curr Drug Metab. 13:1160–1173.
   PubMed Web of Science ®Google Scholar
• Timm DM, Chen J, Sing D, Gage JA, Haisler WL, Neeley SK, Raphael RM, Dehghani M, Rosenblatt KP, Killian TC, et al. 2013. A high-throughput three-dimensional cell migration assay for toxicity screening with mobile device-based macroscopic image analysis. Sci Rep. 3(1):3000.
   PubMedGoogle Scholar
• Tong XF, Zhao FQ, Ren YZ, Zhang Y, Cui YL, Wang QS. 2018. Injectable hydrogels based on glycyrrhizin, alginate, and calcium for three-dimensional cell culture in liver tissue engineering. J Biomed Mater Res. 106(12):3292–3302.
   Web of Science ®Google Scholar
• Tostoes RM, Leite SB, Serra M, Jensen J, Bjorquist P, Carrondo MJ, Brito C, Alves PM. 2012. Human liver cell spheroids in extended perfusion bioreactor culture for repeated‐dose drug testing. Hepatology. 55(4):1227–1236.
   PubMed Web of Science ®Google Scholar
• Underhill GH, Khetani SR. 2018. Bioengineered liver models for drug testing and cell differentiation studies. Cell Mol Gastroenterol Hepatol. 5(3):426–439.
   PubMed Web of Science ®Google Scholar
• Uno Y, Uehara S, Yamazaki H. 2016. Utility of non-human primates in drug development: Comparison of non-human primate and human drug-metabolizing cytochrome P450 enzymes. Biochem Pharmacol. 121:1–7.
   PubMed Web of Science ®Google Scholar
• US patent # 20110053783. 2011. Bioactive surface for hepatocyte-based applications. http://www.freepatentsonline.com/y2011/0053783.
   Google Scholar
• US patent #WO2010031194 2008. Hanging drop plate. http://europepmc.org/article/PAT/WO2010031194.
   Google Scholar
• US Patent #5612188. 1997. Automated, multicompartmental cell culture system. http://www.freepatentsonline.com/5612188.
   Google Scholar
• US Patent #7288405. 2002. Devices and methods for pharmacokinetic-based cell culture system. https://patents.justia.com/patent/7288405.
   Google Scholar
• US Patent #8030061. 2006. Devices and methods for pharmacokinetic-based cell culture system. https://patents.justia.com/patent/8030061.
   Google Scholar
• Van Grunsven LA. 2017. 3D in vitro models of liver fibrosis. Adv Drug Del Rev. 121:133–146.
   PubMed Web of Science ®Google Scholar
• Vernetti L, MacDonald J, Pegg D. 1996. Differential toxicity of an inhibitor of mitochondrial respiration in canine hepatocytes and adrenocortical cell cultures. Toxicol in Vitro. 10(1):51–57.
   PubMed Web of Science ®Google Scholar
• Vorrink S, Zhou Y, Ingelman SM, Lauschke VM. 2018. Prediction of drug-induced hepatotoxicity using long-term stable primary hepatic 3D spheroid cultures in chemically defined conditions. Tox Sci. 163(2):655–665.
   PubMed Web of Science ®Google Scholar
• Walker TM, Rhodes PC, Westmoreland C. 2000. The differential cytotoxicity of methotrexate in rat hepatocyte monolayer and spheroid cultures. Toxicol in Vitro. 14(5):475–485.
   PubMed Web of Science ®Google Scholar
• Wang ZY, Li WJ, Li QG, Jing HS, Yuan TJ, Fu GB, Tang D, Zhang HD, Yan HX, Zhai B. 2019. A DMSO-free hepatocyte maturation medium accelerates hepatic differentiation of HepaRG cells in vitro. Biomed Pharmacother. 116:109010.
   PubMed Web of Science ®Google Scholar
• Whatley BR, Li X, Zhang N, Wen X. 2014. Magnetic-directed patterning of cell spheroids. J Biomed Mater Res. 102(5):1537–1547.
   Web of Science ®Google Scholar
• Wilkening S, Stahl F, Bader A. 2003. Comparison of primary human hepatocytes and hepatoma cell line HepG2 with regard to their biotransformation properties. Drug Metab Dispos. 31(8):1035–1042.
   PubMed Web of Science ®Google Scholar
• Xu J, Ma M, Purcell WM. 2003. Characterisation of some cytotoxic endpoints using rat liver and HepG2 spheroids as in vitro models and their application in hepatotoxicity studies. I. Glucose metabolism and enzyme release as cytotoxic markers. Toxicol Appl Pharmacol. 189(2):100–111.
   PubMed Web of Science ®Google Scholar
• Yanan D, Sermien C, Rongbin H, Shi C, Hui T, Hanry Y. 2006. 3D hepatocyte monolayer on hybrid RGD/galactose substratum. Biomaterials. 27: 5669–5680.
   Google Scholar
• Yang K, Kock K, Sedykh A, Tropsha A, Brouwer KL. 2013. An updated review on drug-induced cholestasis: mechanisms and investigation of physicochemical properties and pharmacokinetic parameters. J Pharm Sci. 102(9):3037–3057.
   PubMed Web of Science ®Google Scholar
• Yokoyama Y, Sasaki Y, Terasaki N, Kawataki T, Takekawa K, Iwase Y, Shimizu T, Sanoh S, Ohta S. 2018. Comparison of drug metabolism and its related hepatotoxic effects in HepaRG, cryopreserved human hepatocytes, and HepG2 cell cultures. Biol Pharm Bull. 41:722–732.
   Web of Science ®Google Scholar
• Yu Y, Alkhawaji A, Ding Y, Mei J. 2016. Decellularized scaffolds in regenerative medicine. Oncotarget. 7(36):58671–58683.
   PubMedGoogle Scholar
• Yuhas JM. 1979. Differential protection of normal and malignant tissues against the cytotoxic effects of mechlorethamine. Cancer Treat Rep. 63(6):971–976.
   PubMedGoogle Scholar
• Zhang B, Li Y, Wang G, Jia Z, Li H, Peng Q, Gao Y. 2018. Fabrication of agarose concave petridish for 3D-culture microarray method for spheroids formation of hepatic cells. J Mater Sci Mater Med. 29(5):49–58.
   PubMed Web of Science ®Google Scholar
• Zhang LW, Koci J, Jeffery B, Riviere JE, Monteiro NA. 2015. Safety assessment of potential food ingredients in canine hepatocytes. Food Chem Toxicol. 78:105–115.
   PubMed Web of Science ®Google Scholar
• Zhang QF, Xue HC, Ning PH, Tao W, Yi CW, X S, Yi TD, Zhong ZG. 2009. The effect of nanofibrous galactosylated chitosan scaffolds on the formation of rat primary hepatocyte aggregates and the maintenance of liver function. Biomaterials. 30:2753–2763.
   PubMed Web of Science ®Google Scholar
• Zhang X, Yang L, Liu Y, Song Z, Zhao J, Chen D, Yu H, Li R, Wang Y, Yang K, et al. 2018. Detection of nanocarrier potentiation on drug induced phospholipidosis in cultured cells and primary hepatocyte spheroids by high content imaging and analysis. Toxicol Appl Pharmacol. 348:54–66.
   PubMed Web of Science ®Google Scholar
• Zhang YN, Poon W, Tavares AJ, McGilvray ID, Chan WC. 2016. Nanoparticle–liver interactions: cellular uptake and hepatobiliary elimination. J Controlled Release. 240:332–348.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Shen J, Lauschke VM. 2019. Comprehensive evaluation of Organotypic and Microphysiological Liver Models for Prediction of Drug-Induced Liver Injury. Front Pharmacol. 10:1093–1115.
   PubMed Web of Science ®Google Scholar
• Zhuang X, Lu C. 2016. The past, current, and future application of cryopreserved human hepatocytes in drug development. Int J Clin Pharmacol Pharmacother. 1:120–123.
   Google Scholar